Advocacy, Partnership, Outreach, and Optimized Care for Latinx colorectal cancer patients
Official title: Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients (APOYO): A Community Health Worker Intervention for Latinx Colorectal Cancer Patients
Run by Stanford University · NCT07403981 · Data updated 2026-11-12
This pilot trial tests a navigator program run by community health workers for newly diagnosed Latinx colorectal cancer patients to see if it improves quality of life and health care use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | July 31, 2028 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07403981 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older who are newly diagnosed with colon or rectal cancer within the last 3 months, who identify as Latinx/Hispanic/Latino, reside in Santa Clara County, and are able to consent in Spanish or English.
✕Probably not a fit
Patients who do not identify as Latinx/Hispanic/Latino, live outside Santa Clara County, or cannot participate in the language requirements may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot feasibility randomized trial recruits newly diagnosed Latinx adults with colon or rectal cancer in Santa Clara County. It uses a CHW/Promotora navigator to coordinate care and connect patients with social services, aiming to improve health-related quality of life, health care utilization, and social needs. The intervention is delivered through existing academic-community partnerships and targets multi-level support. The study will compare navigator-assisted care to standard care to see if the approach is feasible and acceptable. If successful, the program could inform broader efforts to reduce disparities in colorectal cancer outcomes for Latinx patients.
Why it matters
Potential benefit: If successful, participants might experience better quality of life and more efficient use of health services during cancer care.
How similar studies have gone: Prior CHW/Promotora-based navigation efforts in cancer care have shown feasibility and potential improvements in care coordination, though results vary by setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. New diagnosis of colon or rectal cancer in the last 3 months 2. Identify as Latinx/Hispanic/Latino 3. Aged 18 years or older 4. Reside in and planning to receive care in Santa Clara County 5. Ability to understand and the willingness to provide written informed consent Exclusion Criteria: 1. Unable to speak and understand either Spanish or English 2. Any concurrent malignancy other than nonmelanoma skin cancer or carcinoma in situ of the cervix. Patients with any previous malignancy without evidence of disease for \>3 years will be allowed to enter the study
Where it's running
-
Stanford University
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: Aaron J Dawes, MD, PhD — Stanford University
- Study coordinator: Study Coordinator
- Email: apoyo_team@stanford.edu
- Phone: (408) 753-8976
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.